Bone Biologics, Corp.
Cover
Document and Entity Information
Financial Statements
Balance Sheets
Balance Sheets (Parenthetical)
Statements of Operations
Statements of Changes in Stockholder's Equity
Statements of Cash Flows
Notes to Financial Statements
Note 1 - The Company
Note 2 - Summary of Significant Accounting Policies
Note 3 - Equity Securities
Note 4 - Going Concern
Note 5 - Due To Parent
Accounting Policies
Note 2 - Summary of Significant Accounting Policies: Method of Accounting (Policies)
Note 2 - Summary of Significant Accounting Policies: Development Stage (Policies)
Note 2 - Summary of Significant Accounting Policies: Cash and Cash Equivalents (Policies)
Note 2 - Summary of Significant Accounting Policies: Loss Per Common Share (Policies)
Note 2 - Summary of Significant Accounting Policies: Use of Estimates (Policies)
Note 2 - Summary of Significant Accounting Policies: Organizational Costs (Policies)
Note 2 - Summary of Significant Accounting Policies: Income Taxes (Policies)
Note 2 - Summary of Significant Accounting Policies: Financial Instruments (Policies)
Note 2 - Summary of Significant Accounting Policies: Recent Issued Accounting Standards Not Adopted (Policies)
Notes Details
Note 1 - The Company (Details)
Note 4 - Going Concern (Details)
All Reports
Filing Date:
09-15-2014
Form Type:
Form 10-Q
Description:
Quarterly Report